2Seventy Bio Inc
NASDAQ:TSVT
2Seventy Bio Inc
NASDAQ:TSVT
Price:
5
USD
Market Closed
Market Cap:
$266.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
2Seventy Bio Inc
NASDAQ:TSVT
|
US |
|
Andfjord Salmon AS
OSE:ANDF
|
NO |
|
Peak Rare Earths Ltd
ASX:PEK
|
AU |
|
Atos SE
OTC:AEXAF
|
FR |
|
Sojitz Corp
TSE:2768
|
JP |
|
SDX Energy PLC
LSE:SDX
|
UK |
|
S
|
Sharps Technology Inc
NASDAQ:STSS
|
US |
|
Rupa & Company Ltd
NSE:RUPA
|
IN |
|
Lunai Bioworks Inc
NASDAQ:LNAI
|
US |
|
TXNM Energy Inc
NYSE:TXNM
|
US |
Multiples-Based Value
The
Multiples-Based Value for
2Seventy Bio Inc (TSVT)
under the Base Case is
hidden
USD.
Compared with the current market price of 5 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TSVT Multiples-Based Value
LOCKED
Multiples Across Competitors
TSVT Competitors Multiples
2Seventy Bio Inc Competitors
2Seventy Bio Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
2Seventy Bio Inc
NASDAQ:TSVT
|
257.9m USD | 6.8 | -4.5 | -0.9 | -0.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.8B USD | 6 | 87.2 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.3B USD | 5 | 23.7 | 13.8 | 13.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.3B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.7B USD | 9.1 | 27.7 | 20.8 | 21.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.4B USD | 5.6 | 17.8 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD | 3.1 | 33.7 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR | 11.3 | 36.2 | 39.4 | 40.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
